By: Ryan Scott, Chris Ryan
The FDA has awarded rare pediatric disease designation to the novel GSK-3β inhibitor elraglusib for the treatment of Ewing sarcoma.
Ryan Scott is a contributing writer for various publications, including SlashFilm, Texas A&M University-Commerce, FANGORIA, Newswav, and more. With a diverse range of interests, Ryan covers topics such as film, entertainment, technology, healthcare, and more, providing insightful and engaging articles for his readers.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Ryan Scott's coverage includes a mix of entertainment news and gaming, with a focus on box office performance, movie franchises, and industry trends. Pitches to Ryan should highlight insights into box office performances, movie franchises or gaming-related developments.
Given the prevalence of data citations in his articles, he would likely appreciate pitches supported by relevant statistics or research related to box office performance trends or audience preferences in movies and gaming.
As Ryan does not have a specific geographic focus but covers global entertainment news, pitches with an international perspective on box office successes and failures across different regions could be well-received.
This information evolves through artificial intelligence and human feedback. Improve this profile .